Clinical Trials Directory

Trials / Terminated

TerminatedNCT01408212

Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Korean Medicine Hospital of Pusan National University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.

Conditions

Interventions

TypeNameDescription
PROCEDUREAcupuncture treatmentAcupuncture treatment will be performed by licensed doctors in Korean Medicine using 0.20 mm (diameter) X 0.30 mm (length) sized disposable acupuncture on seven to ten consecutive days after admission to the Korean Medicine Hospital of Pusan National University. At least two sessions and a maximum of five sessions of acupuncture therapy will be administered per day. Acupuncture points consist of common points and additional points selected for typical complaints common in patients under chemotherapy. These points are as follows. * Common points: LI4 (bilateral), LU5 (bilateral), LU7 (bilateral), BL13 (bilateral), BL23 (bilateral), SP3 (bilateral), LU9 (bilateral), ST36 (bilateral) and CV22 * Additional points Nausea/vomiting PC6 (bilateral) Dyspepsia: CV12, LU6 (bilateral) Insomnia: Yintang, KI5 (bilateral) Pain: Ashi points (tender spots)

Timeline

Start date
2011-07-01
Primary completion
2012-06-01
Completion
2012-12-01
First posted
2011-08-03
Last updated
2015-09-02

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01408212. Inclusion in this directory is not an endorsement.